Entering text into the input field will update the search result below

Galmed Pharma receives non-compliance letter from Nasdaq

  • Galmed Pharma (NASDAQ:GLMD) said on Friday it had received a letter from the Nasdaq saying that the Company was not in compliance with the minimum bid price requirement for continued listing, which requires listed securities to maintain a minimum bid price of $1.00 per share.
  • The Company has until December 12 to regain compliance with the minimum bid price requirement.
  • The Company can regain compliance, if at any time during this 180 day period, the closing bid price of its ordinary shares is at least $1 for a minimum of ten consecutive business days, it added.

Recommended For You

More Trending News

About GLMD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
GLMD--
Galmed Pharmaceuticals Ltd.